These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25991065)

  • 1. Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.
    Fadke J; Desai J; Thakkar H
    AAPS PharmSciTech; 2015 Dec; 16(6):1434-44. PubMed ID: 25991065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.
    Zhang K; Yu H; Luo Q; Yang S; Lin X; Zhang Y; Tian B; Tang X
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1285-92. PubMed ID: 23562534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Compression on the Molecular Arrangement of Itraconazole-Soluplus Solid Dispersions: Induction of Liquid Crystals or Exacerbation of Phase Separation?
    Singh A; Bharati A; Frederiks P; Verkinderen O; Goderis B; Cardinaels R; Moldenaers P; Van Humbeeck J; Van den Mooter G
    Mol Pharm; 2016 Jun; 13(6):1879-93. PubMed ID: 27092396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of spray dried ternary solid dispersions comprising itraconazole, soluplus and HPMCP: Effect of constituent compositions.
    Davis MT; Potter CB; Mohammadpour M; Albadarin AB; Walker GM
    Int J Pharm; 2017 Mar; 519(1-2):365-372. PubMed ID: 28131850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in vivo human bioavailability of dissolving tablets containing a self-nanoemulsifying itraconazole solid dispersion without precipitation in simulated gastrointestinal fluid.
    Piao ZZ; Choe JS; Oh KT; Rhee YS; Lee BJ
    Eur J Pharm Sci; 2014 Jan; 51():67-74. PubMed ID: 24012590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.
    Dalvadi H; Parmar K; Yadav S
    Drug Dev Ind Pharm; 2019 Jun; 45(6):968-980. PubMed ID: 30784326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid dispersions of itraconazole for inhalation with enhanced dissolution, solubility and dispersion properties.
    Duret C; Wauthoz N; Sebti T; Vanderbist F; Amighi K
    Int J Pharm; 2012 May; 428(1-2):103-13. PubMed ID: 22414388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel tablet formulation of amorphous candesartan cilexetil solid dispersions involving P-gp inhibition for optimal drug delivery: in vitro and in vivo evaluation.
    Surampalli G; Nanjwade BK; Patil PA; Chilla R
    Drug Deliv; 2016 Sep; 23(7):2124-2138. PubMed ID: 25080228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and evaluation of liquisolid compacts of itraconazole to enhance its oral bioavailability.
    Thakkar HP; Vasava D; Patel AA; Dhande RD
    Ther Deliv; 2020 Feb; 11(2):83-96. PubMed ID: 31955698
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of the phase behavior of polyethylene glycol 6000-itraconazole solid dispersions using DSC.
    Wang X; Michoel A; Van den Mooter G
    Int J Pharm; 2004 Mar; 272(1-2):181-7. PubMed ID: 15019081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability.
    Kapsi SG; Ayres JW
    Int J Pharm; 2001 Oct; 229(1-2):193-203. PubMed ID: 11604272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability enhancement of itraconazole-based solid dispersions produced by hot melt extrusion in the framework of the Three Rs rule.
    Thiry J; Kok MG; Collard L; Frère A; Krier F; Fillet M; Evrard B
    Eur J Pharm Sci; 2017 Mar; 99():1-8. PubMed ID: 27951411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a new hydrophilic polymer, Kollicoat IR, in the formulation of solid dispersions of Itraconazole.
    Janssens S; de Armas HN; Remon JP; Van den Mooter G
    Eur J Pharm Sci; 2007 Mar; 30(3-4):288-94. PubMed ID: 17204410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and pharmacokinetic study of itraconazole solid dispersions prepared by solvent-controlled precipitation and spray-dry methods.
    Sim T; Lim C; Lee JW; Kim DW; Kim Y; Kim M; Choi S; Choi HG; Lee ES; Kim KS; Kang W; Oh KT
    J Pharm Pharmacol; 2017 Dec; 69(12):1707-1715. PubMed ID: 28872678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-step preparation and deagglomeration of itraconazole microflakes by supercritical antisolvent method for dissolution enhancement.
    Sathigari SK; Ober CA; Sanganwar GP; Gupta RB; Babu RJ
    J Pharm Sci; 2011 Jul; 100(7):2952-65. PubMed ID: 21344415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced solubility and oral bioavailability of itraconazole by combining membrane emulsification and spray drying technique.
    Choi YK; Poudel BK; Marasini N; Yang KY; Kim JW; Kim JO; Choi HG; Yong CS
    Int J Pharm; 2012 Sep; 434(1-2):264-71. PubMed ID: 22643224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability.
    Thakkar HP; Khunt A; Dhande RD; Patel AA
    J Microencapsul; 2015; 32(6):559-69. PubMed ID: 26333939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
    Pandey S; Patil AT
    Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.